Regulus Therapeutics Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
RGLS Nasdaq 2836 www.regulusrx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Regulus Therapeutics Inc.

Regulus: Q1 Earnings Snapshot - May 8th, 2025 8:49 pm
Regulus Therapeutics Reports First Quarter 2025 Financial Results and Recent Updates - May 8th, 2025 8:05 pm
Novartis to buy Regulus Therapeutics for as much as $1.7 billion - May 2nd, 2025 1:39 pm
Biotech Alert: Searches spiking for these stocks today - May 1st, 2025 4:15 pm
Novartis to strengthen renal disease portfolio with Regulus - May 1st, 2025 11:26 am
Novartis to acquire Regulus in deal for kidney disease drug - Apr 30th, 2025 12:15 pm
Novartis to Acquire Regulus in $1.7 Billion Deal - Apr 30th, 2025 11:50 am
Novartis to buy kidney disease drug maker Regulus in up to $1.7 billion deal - Apr 30th, 2025 11:24 am
Regulus Therapeutics Enters into Agreement to be Acquired by Novartis AG - Apr 30th, 2025 11:00 am
Promising Penny Stocks To Consider In April 2025 - Apr 29th, 2025 12:05 pm
Should You Buy Regulus (RGLS) After Golden Cross? - Apr 24th, 2025 1:55 pm
Is Regulus Therapeutics Inc. (RGLS) the Best Rising Penny Stock to Buy According to Analysts? - Apr 18th, 2025 7:25 pm
Regulus Therapeutics to Present at the 2025 Oppenheimer Innovation on the Island Biotech Summit - Apr 2nd, 2025 12:00 pm
Regulus Therapeutics Leads The Charge Among 3 Promising Penny Stocks - Mar 31st, 2025 11:05 am
Sector Update: Health Care Stocks Advance Late Afternoon - Mar 27th, 2025 7:58 pm
Top Midday Gainers - Mar 27th, 2025 5:58 pm
Regulus Therapeutics Announces Successful Completion of its Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of Farabursen (RGLS8429) for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) - Mar 27th, 2025 11:00 am
Regulus Therapeutics (RGLS): One of the Best Short-Term Stocks to Buy Right Now - Mar 18th, 2025 8:44 am
Is Regulus Therapeutics (NASDAQ:RGLS) In A Good Position To Invest In Growth? - Mar 15th, 2025 12:08 pm
Regulus: Q4 Earnings Snapshot - Mar 13th, 2025 8:18 pm